CXL and the treatment of keratoconus (C-100432)
30 April 2020
Spring 2020
Consultant Ophthalmologist Damian Lake looks at the history of corneal collagen cross-linking in treating keratoconus, the current indications for its use, and the most up-to-date refinements to the procedure.
Domains covered
Communication
Clinical practice
Keratoconus, which causes the cornea to become thinner and steeper, is perhaps most commonly associated with eye rubbing. Regular, traumatic vicissitude of eye rubbing can weaken the cornea, creating bulging, thinning and structural failure. The likely pathogenesis
is multifactorial, with a wide range of genetic loci suggesting the disease is dependent on external influences that lead to initiation and progression.
Associated ocular and systemic conditions include, but are not limited to, atopic eczema, asthma, allergic eye diseases, Down’s syndrome, collagen vascular diseases and retinitis pigmentosa. Keratoconus is known to affect between one in 400 and one in 2000 – mainly young – people worldwide (Godefrooij et al, 2017).
Not already a member of the College?
Start enjoying the benefits of College membership today. Take a look at what the College can offer you and view our membership categories and rates.
Related further reading
In this article we will outline the importance of developing standards for affordable and accessible low-vision service delivery that can be applied globally and that are relevant to both the developed and developing world.
Join us for our upcoming campaign where we will be highlighting the importance of good vision, eye health, and helping the public to #FocusOnLife.
Innovative help for a patient with retinitis pigmentosa suffering from disability and discomfort glare.